0000950170-24-023183 Sample Contracts

4D MOLECULAR THERAPEUTICS, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT

Change in Control and Severance Agreement • February 29th, 2024 • 4D Molecular Therapeutics, Inc. • Biological products, (no disgnostic substances) • California

• Contract Type
  Change in Control and Severance Agreement
• Filed
  February 29th, 2024
• Company
  4D Molecular Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

This Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between (“Executive”) and 4D Molecular Therapeutics, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).

4D MOLECULAR THERAPEUTICS, INC. AMENDED AND RESTATED CHANGE IN CONTROL AND SEVERANCE AGREEMENT

Change in Control and Severance Agreement • February 29th, 2024 • 4D Molecular Therapeutics, Inc. • Biological products, (no disgnostic substances) • California

• Contract Type
  Change in Control and Severance Agreement
• Filed
  February 29th, 2024
• Company
  4D Molecular Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

This Amended and Restated Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Robert Young Kim (“Executive”) and 4D Molecular Therapeutics, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).